721 related articles for article (PubMed ID: 30497404)
1. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.
Todd A; Jansen J; Colvin J; McLachlan AJ
BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404
[TBL] [Abstract][Full Text] [Related]
2. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
[TBL] [Abstract][Full Text] [Related]
3. Optimising Medications for Patients With Cancer and Multimorbidity: The Case for Deprescribing.
Turner JP; Kantilal K; Kantilal K; Holmes HM; Koczwara B
Clin Oncol (R Coll Radiol); 2020 Sep; 32(9):609-617. PubMed ID: 32563549
[TBL] [Abstract][Full Text] [Related]
4. Frailty, polypharmacy and deprescribing.
Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
[TBL] [Abstract][Full Text] [Related]
5. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
Palagyi A; Keay L; Harper J; Potter J; Lindley RI
BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
[TBL] [Abstract][Full Text] [Related]
6. Deprescribing medications in older people: a narrative review.
Salahudeen MS
Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
[TBL] [Abstract][Full Text] [Related]
7. Deprescribing: a new goal focused on the patient.
Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
[TBL] [Abstract][Full Text] [Related]
8. The value of deprescribing in older adults with dementia: a narrative review.
Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
[No Abstract] [Full Text] [Related]
9. New horizons in deprescribing for older people.
Woodford HJ; Fisher J
Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290
[TBL] [Abstract][Full Text] [Related]
10. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN
Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544
[TBL] [Abstract][Full Text] [Related]
11. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
Chou J; Tong M; Brandt NJ
J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate polypharmacy management versus deprescribing: A review on their relationship.
Zidan A; Awaisu A
Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):6-14. PubMed ID: 37350370
[TBL] [Abstract][Full Text] [Related]
13. Issues with deprescribing in haemodialysis: a qualitative study of patient and provider experiences.
Bondurant-David K; Dang S; Levy S; Sperlea D; Vanier MC; Gerardi S; David PM
Int J Pharm Pract; 2020 Dec; 28(6):635-642. PubMed ID: 33094884
[TBL] [Abstract][Full Text] [Related]
14. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
[TBL] [Abstract][Full Text] [Related]
15. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
[TBL] [Abstract][Full Text] [Related]
16. Deprescribing in older people.
O'Mahony MS; Parbhoo A
Br J Hosp Med (Lond); 2020 Jan; 81(1):1-9. PubMed ID: 32003625
[TBL] [Abstract][Full Text] [Related]
17. Advancing the Science of Deprescribing: A Novel Comprehensive Conceptual Framework.
Linsky A; Gellad WF; Linder JA; Friedberg MW
J Am Geriatr Soc; 2019 Oct; 67(10):2018-2022. PubMed ID: 31430394
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
Komagamine J; Sugawara K; Hagane K
BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
[TBL] [Abstract][Full Text] [Related]
19. Deprescribing in Older Adults With Cardiovascular Disease.
Krishnaswami A; Steinman MA; Goyal P; Zullo AR; Anderson TS; Birtcher KK; Goodlin SJ; Maurer MS; Alexander KP; Rich MW; Tjia J;
J Am Coll Cardiol; 2019 May; 73(20):2584-2595. PubMed ID: 31118153
[TBL] [Abstract][Full Text] [Related]
20. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
Ailabouni N; Mangin D; Nishtala PS
Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]